Loading insider details...
Beta
Latest Form 4 (Jul 20, 2026): Conversion of 351,037 CYCN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 20, 2026 | Cyclerion Therapeutics, Inc. (CYCN) | Conversion | 351,037 | n/a |
| Mar 28, 2025 | Cyclerion Therapeutics, Inc. (CYCN) | Grant/Award | 181,818 | $500.0K |
| Jan 26, 2024 | Cyclerion Therapeutics, Inc. (CYCN) | Grant/Award | 15,000 | n/a |
| Dec 4, 2023 | Cyclerion Therapeutics, Inc. (CYCN) | Grant/Award | 20,000 | n/a |
| May 23, 2023 | Cyclerion Therapeutics, Inc. (CYCN) | Grant/Award | 225,000 | $1.95M |
| Jan 24, 2022 | Cyclerion Therapeutics, Inc. (CYCN) | Grant/Award | 52,950 | n/a |
| Jun 7, 2021 | Cyclerion Therapeutics, Inc. (CYCN) | Purchase | 823,170 | $2.70M |
| May 10, 2021 | Cyclerion Therapeutics, Inc. (CYCN) | Purchase | 302,000 | $733.9K |
| May 7, 2021 | Cyclerion Therapeutics, Inc. (CYCN) | Purchase | 300,000 | $687.0K |
| Apr 2, 2020 | Cyclerion Therapeutics, Inc. (CYCN) | Grant/Award | 153,846 | $407.7K |